Sumant Ramachandra - 31 Oct 2024 Form 3 Insider Report for Lyell Immunopharma, Inc. (LYEL)

Role
Director
Signature
/s/ Matthew Lang, as Attorney-in-Fact
Issuer symbol
LYEL
Transactions as of
31 Oct 2024
Net transactions value
$0
Form type
3
Filing time
01 Nov 2024, 16:54:32 UTC
Next filing
25 Mar 2025

No securities are beneficially owned.